Lung Cancer Therapy Annual 7

Highly Commended, BMA Medical Book Awards 2013

Oncology research and practice in lung cancer continues to develop rapidly. This latest edition of an acclaimed reference briefs the oncology community with a review of the recent literature, emphasizing the most significant therapeutic advances. The expert contributions ofLung Cancer Therapy Annual7 offer an update of the impact that this information will have on the day-to-day management of the lung cancer patient.

New to the seventh edition are four new chapters on the treatment of non-small cell lung cancer (NSCLC) and a new chapter on thymoma. Additional topics include:

• Oncogenic driver mutations
• First line therapy of advanced non-small cell lung cancer without activating EGFR mutation
• Second line therapy of non-small cell lung cancer
• Adjunct and neoadjunct therapy of non-small cell lung cancer
• Advances in surgery of lung cancer; advances in radiotherapy of lung cancer
• Mesothelioma
• Thymic tumors